Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) EBT: 2009-2021

Historic EBT for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to -$85.5 million.

  • Avadel Pharmaceuticals' EBT fell 346.73% to -$23.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$88.2 million, marking a year-over-year decrease of 2379.58%. This contributed to the annual value of -$85.5 million for FY2021, which is 364.17% down from last year.
  • As of FY2021, Avadel Pharmaceuticals' EBT stood at -$85.5 million, which was down 364.17% from -$18.4 million recorded in FY2020.
  • Over the past 5 years, Avadel Pharmaceuticals' EBT peaked at $92.7 million during FY2017, and registered a low of -$113.2 million during FY2018.
  • Moreover, its 3-year median value for EBT was -$81.4 million (2019), whereas its average is -$61.8 million.
  • Per our database at Business Quant, Avadel Pharmaceuticals' EBT skyrocketed by 1,053.49% in 2017 and then tumbled by 364.17% in 2021.
  • Yearly analysis of 5 years shows Avadel Pharmaceuticals' EBT stood at $92.7 million in 2017, then slumped by 222.16% to -$113.2 million in 2018, then increased by 28.10% to -$81.4 million in 2019, then spiked by 77.35% to -$18.4 million in 2020, then plummeted by 364.17% to -$85.5 million in 2021.